Browse EX-10 agreements

Document

Exhibit 10.3

RESTRICTED STOCK UNIT AWARD AGREEMENT

VAALCO ENERGY, INC.

2020 LONG TERM INCENTIVE PLAN

Participant: _____________

1.Grant of RSUs. As of the Date of Grant (identified in Section 19 below), VAALCO Energy, Inc., a Delaware corporation (the “Company”) hereby grants restricted stock units (“Restricted Stock Units” or “RSUs”) to the Participant (identified above), an Employee of the Company. Each RSU represents a conditional right to be issued on a future date one newly-issued share of the Company’s common stock, $0.10 par value per share (the “Common Stock”), as identified in Section 19 below (the “Shares”), subject to the terms and conditions of this agreement (the “Agreement”) and the VAALCO Energy, Inc. 2020 Long Term Incentive Plan (the “Plan”). The Plan is hereby incorporated herein in its entirety by reference. In the event of any conflict between the Plan and this Agreement, the terms of the Plan shall govern except as expressly overridden or amended in this Agreement. Any Shares, when issued to the Participant in settlement of the RSUs, s

…

Document

Exhibit 10.1

Performance Hurdles

VAALCO ENERGY, INC.

RESTRICTED STOCK AWARD AGREEMENT

Participant:

THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is

made and entered into by and between VAALCO Energy, Inc., a Delaware corporation (the “Company”) and     , an individual and employee of the Company (the “Participant”), with respect to Awards approved by the Committee on the ___ day of _______, ______ (the “Date of Grant”), subject to the VAALCO Energy, Inc. 2020 Long Term Incentive Plan (the “Plan”). This Agreement is subject to the terms and conditions of the Plan, which is incorporated herein in its entirety by reference. A copy of the Plan has been made available to the Participant. Capitalized terms not otherwise defined in this Agreement shall have the meaning given to such terms in the Plan.

…

Document

Exhibit 10.2

VAALCO ENERGY, INC.

RESTRICTED STOCK AWARD AGREEMENT

Participant:

THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is

made and entered into by and between VAALCO Energy, Inc., a Delaware corporation (the “Company”) and     , an individual and employee of the Company (the “Participant”), with respect to Awards approved by the Committee on the ___ day of _______ (the “Date of Grant”), subject to the VAALCO Energy, Inc. 2020 Long Term Incentive Plan (the “Plan”). This Agreement is subject to the terms and conditions of the Plan, which is incorporated herein in its entirety by reference. A copy of the Plan has been made available to the Participant. Capitalized terms not otherwise defined in this Agreement shall have the meaning given to such terms in the Plan.

…

ESCROW AGREEMENT

 

This agreement is entered into and is effective as of the date signed below (the “Effective Date”), by and among Cycurion, Inc., a Delaware corporation (“Purchaser”), and Ryan Layton, solely in his capacity as the Authorized Representative of the Company Equityholders pursuant to the Merger Agreement (the “Authorized Representative”), and Zions Bancorporation, National Association (“Escrow Agent” or “Zions”). This agreement, together with any and all exhibits, schedules, and other attachments hereto shall be referred to collectively as the “Escrow Agreement”. Purchaser and the Authorized Representative are referred to herein separately as a “Party” and collectively as the “Escrow Parties”.

 

WHEREAS, Purchaser, Cycurion Merger Sub, LLC and Secuvant, LLC (the “Company”) have entered into that certain Merger Agreement, dated as of May 21, 2026 (the “Merger Agreement”), pursuant to which, among other things, Merger Sub will merge with and into the Company;

…

Leak-out AGREEMENT

 

THIS LEAK-OUT AGREEMENT (this “Agreement”) is made and entered into as of June 3, 2026 between (i) Cycurion, Inc., a Delaware corporation (the “Company”), and (ii) the undersigned equityholders (each, a “Holder”) of Secuvant, LLC, a Utah limited liability company. The Company and the Holder are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Merger Agreement (as defined below).

 

WHEREAS, the Company, Cycurion Merger Sub, LLC, and Secuvant, LLC have entered into that certain Merger Agreement dated May 21, 2026 (the “Merger Agreement”), pursuant to which Holder will receive, among other things, equity securities of the Company as part of the Merger Consideration, including shares of the Company’s preferred stock, par value $0.0001 per share (the “Preferred Shares”);

…

LOCK-UP AGREEMENT

 

THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of June 3, 2026 between (i) Cycurion, Inc., a Delaware corporation (the “Company”), and (ii) the undersigned equityholders (each, a “Holder”) of Secuvant, LLC, a Utah limited liability company. The Company and the Holder are sometimes referred to herein individually as a “Party” and, collectively, as the “Parties”. Any capitalized term used but not defined in this Agreement will have the meaning ascribed to such term in the Merger Agreement (as defined below).

…

ADVISORY SERVICES AGREEMENT

 

THIS ADVISORY AGREEMENT (this “Agreement”) is made and entered into as of the Closing Date (the “Effective Date”), by and between Ryan Layton, an individual (“Advisor”), and Cycurion, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not defined herein have the meanings given in the Merger Agreement (as defined below).

 

WHEREAS, pursuant to that certain Merger Agreement, dated as of May 21, 2026, by and among the Company, Cycurion Merger Sub, LLC, and Secuvant, LLC (“Secuvant”) (the “Merger Agreement”), Cycurion Merger Sub, LLC merged with and into Secuvant, with Secuvant surviving as a wholly owned subsidiary of the Company (the “Merger”), with such Merger becoming effective on the Closing Date (as defined in the Merger Agreement);

 

WHEREAS, Advisor previously served as the Chief Executive Officer of Secuvant and possesses substantial knowledge and relationships relating to Secuvant’s business, including the Panoptic product line; and

…

June 3, 2026

 

Danny White

 

Dear Danny:

 

We are pleased to extend this offer of employment to you for the position of Chief Product Officer at Cycurion, Inc. This offer is subject to the successful completion of customary onboarding requirements, including a successful background check, drug screening, and successful completion of your I-9 employment verification.

 

Your at-will employment with Cycurion, Inc. will commence on June 4, 2026. Reporting to the CEO, you will be responsible as Chief Product Officer. KPIs and performance expectations, are included in Exhibit A of this document.

 

Base Salary

 

Your initial base salary will be $185,000 per year, payable in accordance with the Company’s standard payroll practices and subject to applicable tax withholdings.

 

Bonuses

…

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 3, 2026, among Cycurion, Inc., a Delaware corporation (the “Company”), Secuvant, LLC, a Utah limited liability company (“Secuvant”) and the former members of Secuvant listed on the signature page hereof (the “Shareholders”).

 

This Agreement is made pursuant to the Merger Agreement, dated as of May 21, 2026, between the Company, Secuvant and Cycurion Merger Sub, LLC (the “Merger Agreement”).

 

The Company, Secuvant and the Shareholders hereby agree as follows:

 

1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Merger Agreement shall have the meanings given such terms in the Merger Agreement. As used in this Agreement, the following terms shall have the following meanings:

 

“Advice” shall have the meaning set forth in Section 6(c).

…

**BLUEJAY DIAGNOSTICS, INC.

2021 STOCK PLAN, AS AMENDED BY AMENDMENT NO.1 THERETO**

Section 1. Establishment and Purpose.

1.1 The Board of Directors (the “Board”) of Bluejay Diagnostics, Inc. (the “Company”) established the Bluejay Diagnostics, Inc. 2021 Stock Plan (the “Plan”), effective as of July 6, 2021. Amendment No. 1 thereto was approved by the Board on April 28, 2026, and approved by the Company’s stockholders on June 9, 2026.

 

1.2 The purpose of the Plan is to attract and retain outstanding individuals as Key Employees, Directors and Consultants of the Company and its Subsidiaries, to recognize the contributions made to the Company and its Subsidiaries by Key Employees, Directors and Consultants, and to provide such Key Employees, Directors and Consultants with additional incentive to expand and improve the profits and achieve the objectives of the Company and its Subsidiaries, by providing such Key Employees, Directors and Consultants with the opportunity to acquire or increase their proprietary interest in the Company through receipt of Awards.

…

Axsome Therapeutics, Inc.

Executive Severance and Change in Control Plan

ARTICLE I

Statement of Purpose and Effective Date

1.01

 Purpose. Axsome Therapeutics, Inc., a Delaware corporation (the “Company” or “Axsome”), hereby establishes the Axsome Therapeutics, Inc. Executive Severance and Change in Control Plan (the “Plan”). The Plan is intended to encourage and motivate key employees to devote their full attention to the performance of their assigned duties without the distraction or concerns regarding their involuntary termination of employment. The Company believes that it is in the best interests of the shareholders of the Company to provide financial assistance through severance payments and other benefits to eligible key employees who are involuntarily terminated. With respect to each Participant, the Plan supersedes all prior plans, agreements (including employment agreements in effect on or prior to the Effective Date), or other arrangements, in each case, with respect to matters related to severance benefits or enhanced severance payments whether or not before, on or af

…

​

PTC CONSULTING SERVICES AGREEMENT

​

​

​

​

​

​

​

​

​

​

​

This Consulting Services Agreement, effective as June 8, 2026 (the “Effective Date”) between PTC Therapeutics, Inc., a Delaware corporation (“PTC” or the “Company”) and Alethia Young (the “Consultant”).

​

WHEREAS, the Consultant has served as a member of the Board of Directors of PTC (the “Board”), and in such capacity has participated in the oversight of PTC and its activities, until her resignation from the Board effective as of the Effective Date;

​

WHEREAS, the purpose of this Agreement is to confirm the parties’ understanding with respect to (i) Consultant’s rendering consulting services to PTC in exchange for the consideration as further described in this Agreement, and (ii) various related matters, including without limitation Consultant’s obligations to protect information and property which is confidential and proprietary to PTC and its affiliated entities.

​

NOW THEREFORE, PTC and Consultant agree as follows:

​

SERVICES AND NATURE OF ENGAGMENT

…